Institution: University of Birmingham Department: Department of Immunology and Immunotherapy Supervisors: Prof Jessica Blair; Prof Tim Overton Application deadline: Monday,
November 23, 2026 Funding: Competition Funded PhD Project (Students Worldwide) About the Project Antimicrobial resistance (AMR) is a major global health threat. A key determinant of antibiotic efficacy is the intracellular drug concentration, yet our understanding of this parameter is largely based on population-level measurements that mask important cell-to-cell variability. In Gram-negative bacteria, efflux pumps such as AcrAB-TolC export antibiotics and reduce intracellular accumulation. Critically, efflux pump expression is stochastically heterogeneous, even among genetically identical cells, and has been linked to variation in mutation rates(1). We propose that differences in intracellular antibiotic accumulation are an overlooked driver of AMR evolution. Hypothesis: Heterogeneity in intracellular antibiotic accumulation alters the likelihood of survival and resistance evolution at the single-cell level. Aim 1: Map intracellular antibiotic accumulation at single-cell resolution Using flow cytometry, we will quantify heterogeneity in the accumulation of intrinsically fluorescent antibiotics, fluorescent antibiotic probes and fluorescent dyes(2). Fluorescent reporters will be used to correlate gene expression with accumulation patterns. We will determine how these distributions vary across antibiotic classes and growth conditions. Aim 2: Link accumulation states to cellular physiology FACS will isolate low/med/high accumulating cells. These subpopulations will be characterised using phenotypic analyses and RNA sequencing to identify transcriptomic signatures associated with distinct accumulation states and reveal mechanisms underpinning heterogeneity. Aim 3: Determine how accumulation heterogeneity drives resistance evolution We will test whether cells with different accumulation profiles respond differently to antibiotic exposure and whether low accumulators are more likely to survive treatment. By measuring mutation rates in accumulation-stratified populations, we will determine how intracellular drug heterogeneity influences resistance emergence. Funding notes This is a PhD studentship with the Midlands Integrated Biosciences Training Partnership, funded by BBSRC and in partnership with the University of Warwick, University of Birmingham, Aston University, Harper Adams University, Coventry University, and the University of Leicester.


